Machine learning-assisted radiogenomic analysis for miR-15a expression prediction in renal cell carcinoma
- Yulian Mytsyk 1,2, Paweł Kowal 3, Yuriy Kobilnyk 4, Mateusz Lesny 4, Michał Skrzypczyk 5, Dmytro Stroj 6, Victor Dosenko 6, Olena Kucheruk 7
- Yulian Mytsyk 1,2, Paweł Kowal 3, Yuriy Kobilnyk 4
- 1Voxel Medical Diagnostic Centers, Katowice, Poland. mytsyk.yulian@gmail.com.
- 2Department of Urology, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine. mytsyk.yulian@gmail.com.
- 3Department of Urology, Regional Specialist Hospital, Wroclaw, Poland.
- 4Department of Urology, St. Padre Pio Regional Hospital in Przemysl, Przemysl, Poland.
- 5Department of Urology, Centre of Postgraduate Medical Education, Independent Public Hospital of Prof. W. Orlowski, Warsaw, Poland.
- 6Department of General and Molecular Pathophysiology, Bogomoletz Institute of Physiology of National Academy of Sciences of Ukraine, Kiev, Ukraine.
- 7Visio-Med, Kąty Wrocławskie, Poland.
- 0Voxel Medical Diagnostic Centers, Katowice, Poland. mytsyk.yulian@gmail.com.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Machine learning models predict microRNA-15a (miR-15a) expression in renal cell carcinoma (RCC) using radiogenomics. This non-invasive approach aids in stratifying tumors for personalized RCC management.
Area Of Science
- Oncology
- Radiology
- Genomics
- Machine Learning
Background
- Renal cell carcinoma (RCC) outcomes vary significantly.
- MicroRNA-15a (miR-15a) is a prognostic biomarker in RCC, influencing angiogenesis, apoptosis, and proliferation.
- Radiogenomics integrates imaging features with molecular data for non-invasive biomarker prediction.
Purpose Of The Study
- To develop a machine learning-assisted radiogenomic model for predicting miR-15a expression in RCC.
- To correlate radiological features with miR-15a expression levels.
- To stratify RCC tumors based on miR-15a expression and aggressiveness.
Main Methods
- Retrospective analysis of 64 RCC patients with preoperative CT/MRI.
- Evaluation of radiological features (tumor size, necrosis, enhancement).
- Quantification of miR-15a expression via qPCR; prediction using Polynomial regression and Random Forest models; phenotypic stratification using hierarchical clustering and K-means analysis.
Main Results
- Tumor size was the strongest predictor of miR-15a expression (adjusted R²=0.8281, p<0.001).
- High miR-15a correlated with necrosis and nodular enhancement; low levels associated with cystic components and fat.
- Random Forest model explained 65.8% of miR-15a expression variance (R²=0.658); classifier achieved AUC 1.0, precision 1.0, recall 0.9, F1-score 0.95.
Conclusions
- Machine learning-based radiogenomics offers a robust, non-invasive method for predicting miR-15a expression in RCC.
- This approach enhances tumor stratification and supports personalized RCC management.
- Integrating radiological and molecular data is crucial for advancing precision medicine in oncology.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

